The Technical Analyst
Select Language :
TG Therapeutics Inc [TGTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

TG Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

TG Therapeutics Inc is listed at the  Exchange

-2.12% $15.24

America/New_York / 28 mar 2024 @ 10:10


TG Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2 353.38 mill
EPS: 0.0900
P/E: 169.33
Earnings Date: Apr 28, 2024
SharesOutstanding: 154.42 mill
Avg Daily Volume: 4.60 mill
RATING 2024-03-27
B
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 169.33 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
28.81x
Company: PE 169.33 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 14.17 - 16.37

( +/- 7.22%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-13 Lonial Sagar Sell 5 000 Common Stock
2024-03-12 Charney Laurence N Sell 22 000 Common Stock
2024-02-14 Power Sean A Buy 0
2024-01-05 Charney Laurence N Sell 17 500 Common Stock
2024-01-06 Weiss Michael S Buy 1 001 908 Common Stock
INSIDER POWER
84.24
Last 94 transactions
Buy: 12 977 390 | Sell: 1 920 924

Forecast: 11:49 - $15.36

Live Trading Signals (every 1 min)

Forecast 1: 10:19 - $15.27
Forecast 2: 11:09 - $15.30
Forecast 3: 11:49 - $15.36
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $15.24 (-2.12% )
Volume 0.174 mill
Avg. Vol. 4.60 mill
% of Avg. Vol 3.77 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for TG Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for TG Therapeutics Inc

RSI

Intraday RSI14 chart for TG Therapeutics Inc

Last 10 Buy & Sell Signals For TGTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$14.58N/AActive
Profile picture for
            TG Therapeutics Inc

TGTX

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. TG Therapeutics, Inc. was incorporated in 1993 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
WBAMar 28 - 10:07$20.79
ITCIMar 28 - 10:04$69.13
MSTRMar 28 - 10:02$1 917.00
HUNTUSDMar 28 - 10:020.516
FLIPUSDMar 28 - 09:585.51
DUOLMar 28 - 10:00$218.89
MUMar 28 - 09:57$117.64
FTNUSDMar 28 - 09:541.820
ASNDMar 28 - 09:55$145.91
CTUSXMar 28 - 09:55$90.95

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.